|
Showing 1 - 1 of
1 matches in All Departments
Lung cancer is one of the leading causes of death world-wide with
the majority of patients suffering from advanced unresectable or
metastatic non-small cell lung cancer. Despite the advances in
palliative chemotherapy, the survival rate for patients with this
advanced disease treated with chemotherapy remains poor. In this
book, the authors present topical research in the study of lung
cancer treatments including epidermal growth factor tyrosine kinase
inhibitors, in the management of advanced stage non-small cell lung
cancer; lung cancer brachytherapy; volumetric modulated arc therapy
and future individualised therapy for lung cancer in post-genomic
era.
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.